Comment on: Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study, by Ernberg, Hedenberg-Magnusson, List, and Svensson
- PMID: 21737201
- DOI: 10.1016/j.pain.2011.06.010
Comment on: Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study, by Ernberg, Hedenberg-Magnusson, List, and Svensson
Comment on
-
Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study.Pain. 2011 Sep;152(9):1988-1996. doi: 10.1016/j.pain.2011.03.036. Epub 2011 Apr 22. Pain. 2011. PMID: 21514731 Clinical Trial.
References
-
- Cohen J. The statistical power of abnormal-social psychological research: a review. J Abnorm Soc Psychol. 1962;65:145-153.
-
- Dao TT, Lavigne GJ, Charbonneau A, Feine JS, Lund JP. The efficacy of oral splints in the treatment of myofascial face pain of the jaw muscles: a controlled clinical trial. Pain. 1994;56:85-94.
-
- Ernberg M, Hedenberg-Magnusson B, List T, Swensson P. Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study. Pain. 2011;152:1988-1996.
-
- Guarda-Nardini L, Manfredini D, Salamone M, Salmaso L, Tonello S, Ferronato G. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. J Cranio. 2008;26:1-10.
-
- Merskey H. Distortion of the biopsychosocial approach. Pain. 2005;113:240-242.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
